<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Chemometec — Februar 2024]]></title><description><![CDATA[<p dir="auto">Jeg har intet imod shorting og synes private investorer har det med at se syner og overdrive konsekvenserne heraf. Hvis chem performede, så ville shorterne ikke have noget at leve af. Men chem performer ikke, de kommer ikke med noget, intet nyt om tiltag, ingenstrategiske initiativer, der kan ændre udviklingen…de kommer med INGENTING, og derfor har kursen det svært</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400017/chemometec-februar-2024</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 21:38:10 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400017.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 01 Feb 2024 08:10:52 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Thu, 29 Feb 2024 10:03:38 GMT]]></title><description><![CDATA[<p dir="auto">Det lysner <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":)" alt="🙂" /> 500+ er pludselig ikke så langt væk mere…Lad os håbe<br />
det fortsætter <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961676</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961676</guid><dc:creator><![CDATA[Aps_invest]]></dc:creator><pubDate>Thu, 29 Feb 2024 10:03:38 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Thu, 29 Feb 2024 07:21:42 GMT]]></title><description><![CDATA[<p dir="auto">Verus - med 50 centre hvor mange instrumenter tror du at de skal bruge</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961672</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961672</guid><dc:creator><![CDATA[Pappi]]></dc:creator><pubDate>Thu, 29 Feb 2024 07:21:42 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Thu, 29 Feb 2024 04:28:12 GMT]]></title><description><![CDATA[<p dir="auto">Shortpositioner på danske aktier <a href="https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions" rel="nofollow ugc">https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961674</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961674</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 29 Feb 2024 04:28:12 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 19:24:44 GMT]]></title><description><![CDATA[<p dir="auto"><a href="https://www.iovance.com/uploads/Natarajan_IOV-4001-preclinical-poster_AACR-2022-1809-publication.pdf" rel="nofollow ugc">https://www.iovance.com/uploads/Natarajan_IOV-4001-preclinical-poster_AACR-2022-1809-publication.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961677</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961677</guid><dc:creator><![CDATA[MLR]]></dc:creator><pubDate>Tue, 27 Feb 2024 19:24:44 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 19:24:27 GMT]]></title><description><![CDATA[<p dir="auto"><a href="https://www.iovance.com/uploads/Iovance-SITC-2021-EXP-Bag-Poster.pdf" rel="nofollow ugc">https://www.iovance.com/uploads/Iovance-SITC-2021-EXP-Bag-Poster.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961670</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961670</guid><dc:creator><![CDATA[MLR]]></dc:creator><pubDate>Tue, 27 Feb 2024 19:24:27 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 19:23:32 GMT]]></title><description><![CDATA[<p dir="auto">Det ligner at NC-200 før er blevet brugt af Iovance til validering af Amtagvi:</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961669</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961669</guid><dc:creator><![CDATA[MLR]]></dc:creator><pubDate>Tue, 27 Feb 2024 19:23:32 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 14:31:18 GMT]]></title><description><![CDATA[<p dir="auto">Iovance has on-boarded 30 designated centers ready to treat patients at the drug’s launch, and the company is on track to have more than 50 centers in about 100 days, Iovance’s commercial chief, Jim Ziegler, said on the call. <a href="https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor" rel="nofollow ugc">https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961675</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961675</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Tue, 27 Feb 2024 14:31:18 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 14:29:28 GMT]]></title><description><![CDATA[<p dir="auto">Med et, på den korte bane, følgende salg af et større antal instrumenter og forbrugsvarer.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961671</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961671</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Tue, 27 Feb 2024 14:29:28 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 14:27:14 GMT]]></title><description><![CDATA[<p dir="auto">Med baggrund i Chemm`s Linkedin opslag vedrørende godkendelse af Iovance's Amtagvi TIL celle terapi, antager jeg at NC-202 indgår i valideringen af Amtagvi. Så vi bør kunne indregne, at endnu en kunde har fået godkendt deres celle terapi.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961665</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961665</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Tue, 27 Feb 2024 14:27:14 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 08:46:23 GMT]]></title><description><![CDATA[<p dir="auto">Det lader til at det første Fase 3 forsøg med Car-T behandling af faste tumorer er blevet "fasttracked" af FDA. Chemm mener at eksisterende celletæller samt Xcyto 5 er ideelle til denne type behandling. Se deres opslag på linkedin her : <a href="https://www.linkedin.com/feed/update/urn:li:activity:7166739097409994752/?origin=NETWORK_CONVERSATIONS&amp;midToken=AQH2eJ6K7QgO3A&amp;midSig=2mJdxS5wwoDr81&amp;trk=eml-email_network_conversations_01-network~post~cta-0-read~more&amp;trkEmail=eml-email_network_conversations_01-ne" rel="nofollow ugc">https://www.linkedin.com/feed/update/urn:li:activity:7166739097409994752/?origin=NETWORK_CONVERSATIONS&amp;midToken=AQH2eJ6K7QgO3A&amp;midSig=2mJdxS5wwoDr81&amp;trk=eml-email_network_conversations_01-network~post~cta-0-read~more&amp;trkEmail=eml-email_network_conversations_01-ne</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961666</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961666</guid><dc:creator><![CDATA[pwp1965]]></dc:creator><pubDate>Tue, 27 Feb 2024 08:46:23 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Tue, 27 Feb 2024 08:33:01 GMT]]></title><description><![CDATA[<p dir="auto">Pensionisten. Nej det var nok for optimistisk at høre nyt fra selskabet.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961667</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961667</guid><dc:creator><![CDATA[michou]]></dc:creator><pubDate>Tue, 27 Feb 2024 08:33:01 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Mon, 26 Feb 2024 22:47:18 GMT]]></title><description><![CDATA[<p dir="auto">Undskyld, skulle være vedr. XM30</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961673</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961673</guid><dc:creator><![CDATA[Pensionisten]]></dc:creator><pubDate>Mon, 26 Feb 2024 22:47:18 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Mon, 26 Feb 2024 22:46:20 GMT]]></title><description><![CDATA[<p dir="auto"><a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/michou" aria-label="Profile: michou">@<bdi>michou</bdi></a>. Evt. børsmedd. vedr. Xm40? Jeg forventer ikke voldsom megen information løbende <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f609.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--wink" style="height:23px;width:auto;vertical-align:middle" title=";-)" alt="😉" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961664</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961664</guid><dc:creator><![CDATA[Pensionisten]]></dc:creator><pubDate>Mon, 26 Feb 2024 22:46:20 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Mon, 26 Feb 2024 05:11:43 GMT]]></title><description><![CDATA[<p dir="auto">Shortpositioner på dansk aktier: <a href="https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions" rel="nofollow ugc">https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961662</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961662</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 26 Feb 2024 05:11:43 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 23 Feb 2024 22:31:50 GMT]]></title><description><![CDATA[<p dir="auto">Xm. 30 står stadig som coming soon. Mon ikke det udløser en børsmeddelse når første salg har fundet sted.?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961663</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961663</guid><dc:creator><![CDATA[michou]]></dc:creator><pubDate>Fri, 23 Feb 2024 22:31:50 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 23 Feb 2024 22:28:13 GMT]]></title><description><![CDATA[<p dir="auto">Jeps det er godt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961657</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961657</guid><dc:creator><![CDATA[michou]]></dc:creator><pubDate>Fri, 23 Feb 2024 22:28:13 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 23 Feb 2024 18:50:49 GMT]]></title><description><![CDATA[<p dir="auto">kræftfremkaldende stof Trypan Blue.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961668</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961668</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Fri, 23 Feb 2024 18:50:49 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 23 Feb 2024 18:50:01 GMT]]></title><description><![CDATA[<p dir="auto">XM40 skal primært konkurrere med Vi-Cell Blue. MX40 er over 3 gange hurtigere, forbruger 1/5 celle volumen, har en præcision der er over 3 gange bedre og kan tælle samples med 6 gange større celle koncentration. Og så bruger den ikke det</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961656</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961656</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Fri, 23 Feb 2024 18:50:01 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 23 Feb 2024 17:58:05 GMT]]></title><description><![CDATA[<p dir="auto">Xcytomatic 40 præsenteres ikke længere som coming (men altså som på markedet)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961660</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961660</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Fri, 23 Feb 2024 17:58:05 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 23 Feb 2024 04:36:38 GMT]]></title><description><![CDATA[<p dir="auto">Shortpositioner på danske aktier <a href="https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions" rel="nofollow ugc">https://oam.finanstilsynet.dk/#!/stats-and-extracts-short-net-positions</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961655</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961655</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 23 Feb 2024 04:36:38 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Mon, 19 Feb 2024 11:25:23 GMT]]></title><description><![CDATA[<p dir="auto"><a href="https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor" rel="nofollow ugc">https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor</a> FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961658</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961658</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Mon, 19 Feb 2024 11:25:23 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Fri, 16 Feb 2024 05:28:33 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> ja dejligt TheNote fodrer os med info tak <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=f7c67da021e" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961654</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961654</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Fri, 16 Feb 2024 05:28:33 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Thu, 15 Feb 2024 14:11:31 GMT]]></title><description><![CDATA[<p dir="auto">Spørgsmålet er bare om det stadig er Xcyto10 og den patenteret software der er aktuelt i CARE-DNA?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961652</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961652</guid><dc:creator><![CDATA[Verus]]></dc:creator><pubDate>Thu, 15 Feb 2024 14:11:31 GMT</pubDate></item><item><title><![CDATA[Reply to Chemometec — Februar 2024 on Thu, 15 Feb 2024 13:57:14 GMT]]></title><description><![CDATA[<p dir="auto">Tak for info, the Note, om eccdna. Jeg husker godt dine oplysninger og skriw om Regenberg, som jo åbenbart har stiftet et firma, Care-dna. Men det hele lyder jo yderst spændende for vi Chemometec aktionærer, som troligt holder fast endnu. Men mangler information om fremtiden. Endnu en gang tak for dine altid interessante indput, the Note.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7961653</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7961653</guid><dc:creator><![CDATA[puffin]]></dc:creator><pubDate>Thu, 15 Feb 2024 13:57:14 GMT</pubDate></item></channel></rss>